Virtual Reality Immersive Method for Spider (Phobia) Exposure Therapy (VIMSE) — VIMSE

Phobia, Specific Clinical Trial

Official title:
Single-session Gamified Virtual Reality Exposure Therapy for Spider Phobia vs. Traditional Exposure Therapy: a Randomized Controlled Non-inferiority Trial

Status Completed

Clinical Trial Summary

The aim of this study is to examine the efficacy of virtual reality exposure therapy as a treatment for specific phobia (spiders). A gamified virtual reality simulation of one-session therapy (VR-OST) will be compared to the gold-standard treatment in the form of traditional one-session phobia treatment (OST) using in-vivo stimuli. This study was powered to detect a non-inferiority margin of a 2-point difference between groups.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02533310
Study type	Interventional
Source	Stockholm University
Contact
Status	Completed
Phase	N/A
Start date	August 1, 2015
Completion date	April 30, 2019

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02622087` - The Impact of Sex Hormones on One-session Treatment for Spider Phobia in Women	N/A
	Completed	`NCT02789813` - Influence of Valproic Acid on Extinction-based Therapy in Patients With Fear of Spiders.	Phase 2